Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...

Leading the charge this morning is Smith & Nephew PLC (LSE:SN), up over 11% after the knee- and hip-replacement group ...

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

XAU/USD consolidates above the 50-day MA, as softer U.S. data boosts rate cut odds. Gold price future hinges on inflation and ...

The Bitcoin market continues to find a bit of support for the market near the 50 Day EMA, as we are somewhat sluggish, but the bears certainly haven’t taken over either. At this point, the market is ...

The issuer is solely responsible for the content of this announcement.

Second Quarter 2025 Results Key Financial Results Revenue: US$14.7b (up 10% from 2Q 2024).

Glencore has decided against moving its UK listing to the United States, the global miner and trader said on Wednesday, as it ...

And better still, healthy and growing dividend-paying stocks tend to increase their payouts over time. Pfizer's total annual ...

US stocks end lower after data show higher prices and lower employment. Investors also weigh earnings and Trump tariff threats.